10x Genomics filed a lawsuit against Element Biosciences alleging patent infringement tied to Element’s Aviti24 multiomic platform. The complaint, filed in U.S. District Court for the District of Delaware, targets multiple U.S. patents covering spatial technology intellectual property licensed from Harvard University. 10x is seeking monetary damages, attorney’s fees, and a permanent injunction, while Element disputes the allegations and says it will defend the technology vigorously. Element’s Aviti24 roadmap includes plans for in-tissue spatial sequencing products for both fresh-frozen and FFPE tissue later this year. The dispute reflects intensifying competition in in situ spatial genomics and the stakes of patent coverage as next-generation platforms scale beyond research use.